Venture
Personal Genome Diagnostics Inc.
Latest Form D 2021-02-23- CIK 1530958
- State MD
- Biotechnology
- 8 Form D offerings since 2011-09-23
- Total sold
- $198M
- across 8 offerings
- Rounds
- 8
- Form D offerings since 2011-09-23
- Latest round
- $97.7M
- 2021-02-23 · 021-390203
- Investors
- 38
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2021-02-23 · $97.7M
- 2011-09-23$500K021-166311
- 2014-03-17$2M021-213745
- 2015-06-03$4.3M021-241069
- 2015-11-06$20.5M021-250836
- 2017-10-30$65.4M021-297722
- 2019-06-24$5M021-342633
- 2020-05-26$2.8M021-367669
- 2021-02-23$97.7M021-390203
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($97.7M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-390203 | First filed2021-02-23 | Latest2021-02-23 | Sought$98.3M | Sold$97.7M | Investors38 | Exemptions506(b) |
| 021-367669 | First filed2020-05-26 | Latest2020-05-26 | Sought$3.6M | Sold$2.8M | Investors2 | Exemptions506(b) |
| 021-342633 | First filed2019-06-24 | Latest2019-06-24 | Sought$20M | Sold$5M | Investors1 | Exemptions506(b) |
| 021-297722 | First filed2017-10-30 | Latest2017-10-30 | Sought$112M | Sold$65.4M | Investors12 | Exemptions506(b) |
| 021-250836 | First filed2015-11-06 | Latest2015-11-06 | Sought$21.4M | Sold$20.5M | Investors22 | Exemptions506(b) |
| 021-241069 | First filed2015-06-03 | Latest2015-06-03 | SoughtIndefinite | Sold$4.3M | Investors18 | Exemptions506(b) |
| 021-213745 | First filed2014-03-17 | Latest2014-03-17 | Sought$3.5M | Sold$2M | Investors2 | Exemptions506(b) |
| 021-166311 | First filed2011-09-23 | Latest2011-09-23 | Sought$500K | Sold$500K | Investors1 | Exemptions504 |
Who backs Personal Genome Diagnostics Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-02-23
| Name | Relationship |
|---|---|
| Luis A. Diaz, Jr. | RelationshipDirector |
| Victor Velculescu | RelationshipDirector |
| Justin Klein | RelationshipDirector |
| Megan Bailey | RelationshipExecutive Officer, Director |
| Scott Gotshall | RelationshipExecutive Officer |
| James LaFrance | RelationshipDirector |
| Samuel Anguioli | RelationshipExecutive Officer |
| Kavita Patel | RelationshipDirector |
| Kevin Reidy | RelationshipDirector |
| Jack Crowley | RelationshipExecutive Officer |
| Lily Li | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| John K. Dierkes | CRD1629115 | Broker-dealerPickwick Capital Partners, LLC · CRD 130672 | Offerings2 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Maryland (MD)
- Exemptions
- Rule 506(b); Rule 504(b)(1) (not (i), (ii) or (iii))
- First filed
- 2011-09-23
- Latest filing
- 2021-02-23
Who backs Personal Genome Diagnostics Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗